Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 1 completed trials

    Completion Rate
    100%(1/1)
    Active Trials
    2(67%)
    Results Posted
    100%(1 trials)

    Phase Distribution

    Phase 1
    3
    100%

    Phase Distribution

    3

    Early Stage

    0

    Mid Stage

    0

    Late Stage

    Phase Distribution3 total trials
    Phase 1Safety & dosage
    3(100.0%)

    Highest Phase Reached

    Phase 1

    Trial Status & Enrollment

    Completion Rate

    100.0%

    1 of 1 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    2

    trials recruiting

    Total Trials

    3

    all time

    Status Distribution
    Active(2)
    Completed(1)

    Detailed Status

    Active, not recruiting2
    Completed1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    3
    Active
    2
    Success Rate
    100.0%
    Most Advanced
    Phase 1

    Trials by Phase

    Phase 13 (100.0%)

    Trials by Status

    active_not_recruiting267%
    completed133%

    Recent Activity

    2 active trials
    Showing 3 of 3
    active_not_recruitingphase_1

    Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition

    NCT02404688
    active_not_recruitingphase_1

    Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Substudy III

    NCT02710331
    completedphase_1

    Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans

    NCT01590277

    Clinical Trials (3)

    Showing 3 of 3 trials
    NCT02404688Phase 1

    Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition

    Active Not Recruiting
    NCT02710331Phase 1

    Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Substudy III

    Active Not Recruiting
    NCT01590277Phase 1

    Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans

    Completed

    All 3 trials loaded

    Drug Details

    Intervention Type
    Drug
    Total Trials
    3